IDEX Biometrics ASA
IDBA · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $4 | $4 | $3 | $1 |
| % Growth | 1.5% | 44.1% | 159.4% | – |
| Cost of Goods Sold | $4 | $3 | $1 | $0 |
| Gross Profit | $0 | $1 | $2 | $1 |
| % Margin | 5.6% | 20.7% | 55.8% | 74.9% |
| R&D Expenses | $4 | $3 | $3 | $2 |
| G&A Expenses | $0 | $19 | $21 | $21 |
| SG&A Expenses | $14 | $19 | $21 | $21 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | $9 | $10 | $9 | $4 |
| Operating Expenses | $27 | $32 | $33 | $27 |
| Operating Income | -$27 | -$31 | -$31 | -$26 |
| % Margin | -648.6% | -766.6% | -1,103.9% | -2,411.1% |
| Other Income/Exp. Net | -$244 | -$1 | -$1 | -$0 |
| Pre-Tax Income | -$271 | -$33 | -$32 | -$27 |
| Tax Expense | -$0 | -$0 | $0 | -$0 |
| Net Income | -$27 | -$33 | -$33 | -$27 |
| % Margin | -643.4% | -798.1% | -1,146.1% | -2,442.9% |
| EPS | -1.07 | -0.15 | -0.2 | -0.15 |
| % Growth | -613.3% | 25% | -33.3% | – |
| EPS Diluted | -1.07 | -0.15 | -0.2 | -0.15 |
| Weighted Avg Shares Out | 253 | 205 | 184 | 153 |
| Weighted Avg Shares Out Dil | 253 | 206 | 188 | 155 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $13 | $15 | $16 |
| EBITDA | -$274 | -$30 | -$30 | -$25 |
| % Margin | -6,595.7% | -731.2% | -1,040% | -2,251.8% |